Skip to main content
Log in

Komplementäre Onkologie und Prognose

Haben naturheilkundliche Methoden einen Einfluss auf den Krankheitsverlauf?

Complementary medicine in oncology and prognosis

Do naturopathic methods influence the course of the disease?

  • Leitthema
  • Published:
Der Onkologe Aims and scope

Zusammenfassung

Hintergrund

Maßnahmen außerhalb der konventionellen Medizin werden von Patienten genutzt, um die Heilungschancen zu verbessern.

Ziel

Dieser Beitrag versucht die Frage zu beantworten, ob komplementäronkologische Maßnahmen geeignet sind, eine Verbesserung der Heilungschancen bei malignen Tumorerkrankungen zu bewirken.

Material und Methoden

Es erfolgte eine umfangreiche Literaturrecherche.

Ergebnisse

Es besteht die Möglichkeit, dass es durch 1. verschiedene Ansätze möglich ist, die Verträglichkeit der Behandlung zu verbessern, wodurch sich seltener Therapieabbrüche und/oder eine höhere Dosisintensität ergibt, was nachweislich mit einer besseren Prognose einhergeht, 2. komplementäre Methoden die Wirksamkeit der Methoden der klassischer Medizin erhöhen können und 3. sich komplementäre Methoden zur Verhinderung des Rezidivs eignen können, nachdem die klassische Therapie beendet ist.

Schlussfolgerung

Voraussetzung für eine Verbesserung der Prognose scheinen rational begründbare Ansätze zu sein, die die Situation des Patienten, die Tumorentität und die Therapie berücksichtigen. Es finden sich keine Hinweise dafür, dass beliebige, irrationale oder esoterische Therapiekonzepte ebenfalls zu einer Prognoseverbesserung beitragen könnten.

Abstract

Background

Methods outside the field of conventional medicine are frequently used by cancer patients to improve the chance of finding a cure.

Aim

This article attempts to answer the question whether methods from complementary medicine can improve the prognosis of patients with malignant diseases.

Material and methods

A comprehensive literature search was carried out.

Results

It has been shown that there is a chance for improvement in the tolerance of treatment because 1) various methods can reduce the side effects of conventional forms of treatment, which leads to better adherence to classical treatment approaches and higher dose densities. Both have been shown to lead to a better prognosis; 2) methods from complementary medicine can improve the efficacy of methods from conventional medicine and 3) methods from complementary medicine can reduce the likelihood of a recurrence after termination of classical treatment.

Conclusion

A rational approach to complementary medicine is a prerequisite for improving the prognosis. The patient situation, tumor entity and current treatment must be considered when a method from complementary medicine is selected on the basis of evidence-based medicine. There is no evidence that arbitrary, irrational or esoteric concepts also contribute to improvement of the prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Adisa AO, Lawal OO, Adesunkanmi AR (2008) Paradox of wellness and nonadherence among Nigerian women on breast cancer chemotherapy. J Cancer Res Ther 4:107–110

    Article  PubMed  Google Scholar 

  2. Bittenbring JT, Neumann F, Altmann B, Achenbach M, Reichrath J, Ziepert M, Geisel J, Regitz E, Held G, Pfreundschuh M (2014) Vitamin d deficiency impairs rituximab-mediated cellular cytotoxicity and outcome of patients with diffuse large B‑cell lymphoma treated with but not without rituximab. J Clin Oncol 32:3242–3248

    Article  CAS  PubMed  Google Scholar 

  3. Chi F, Wu R, Zeng YC, Xing R, Liu Y, Xu ZG (2013) Post-diagnosis soy food intake and breast cancer survival: a meta-analysis of cohort studies. Asian Pac J Cancer Prev 14:2407–2412

    Article  PubMed  Google Scholar 

  4. Cho HK, Jeong YM, Lee HS, Lee YJ, Hwang SH (2015) Effects of honey on oral mucositis in patients with head and neck cancer: a meta-analysis. Laryngoscope 125:2085–2092

    Article  PubMed  Google Scholar 

  5. Fink M (2011) Vitamin D deficiency is a cofactor of chemotherapy-induced mucocutaneous toxicity and dysgeusia. J Clin Oncol 29:e81–e82

    Article  PubMed  Google Scholar 

  6. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Trudeau ME, Hood N (2003) Diet and breast cancer: evidence that extremes in diet are associated with poor survival. J Clin Oncol 21:2500–2507

    Article  PubMed  Google Scholar 

  7. Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Gomez SL, Miles S, Neugut AI (2010) Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 28:4120–4128

    Article  PubMed  PubMed Central  Google Scholar 

  8. Khan M, Maryam A, Mehmood T, Zhang Y, Ma T (2015) Enhancing activity of anticancer drugs in multidrug resistant tumors by modulating p‑glycoprotein through dietary nutraceuticals. Asian Pac J Cancer Prev 16:6831–6839

    Article  PubMed  Google Scholar 

  9. Li Z, Carrier L, Rowan BG (2008) Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells. Mol Cancer Ther 7:3056–3063

    Article  CAS  PubMed  Google Scholar 

  10. Ling WM, Lui LY, So WK, Chan K (2014) Effects of acupuncture and acupressure on cancer-related fatigue: a systematic review. Oncol Nurs Forum 41:581–592

    Article  PubMed  Google Scholar 

  11. Meneses-Echávez JF, González-Jiménez E, Ramírez-Vélez R (2015) Effects of supervised exercise on cancer-related fatigue in breast cancer survivors: a systematic review and meta-analysis. BMC Cancer 15:77

    Article  PubMed  PubMed Central  Google Scholar 

  12. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L (2014) Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLOS ONE 9:e107418

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ogunleye AA, Xue F, Michels KB (2010) Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res Treat 119:477–484

    Article  PubMed  Google Scholar 

  14. Qi Y, Fu X, Xiong Z, Zhang H, Hill SM, Rowan BG, Dong Y (2012) Methylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancer. PLOS ONE 7:e31539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG (2015) Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database Syst Rev 12:CD011552

    Google Scholar 

  16. Song HJ, Seo HJ, Lee H, Son H, Choi SM, Lee S (2015) Effect of self-acupressure for symptom management: a systematic review. Complement Ther Med 23:68–78

    Article  CAS  PubMed  Google Scholar 

  17. Tang WR, Chen WJ, Yu CT, Chang YC, Chen CM, Wang CH, Yang SH (2014) Effects of acupressure on fatigue of lung cancer patients undergoing chemotherapy: an experimental pilot study. Complement Ther Med 22:581–591

    Article  PubMed  Google Scholar 

  18. Trudel D, Labbé DP, Araya-Farias M, Doyen A, Bazinet L, Duchesne T, Plante M, Grégoire J, Renaud MC, Bachvarov D, Têtu B, Bairati I (2013) A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. Gynecol Oncol 131:357–361

    Article  PubMed  Google Scholar 

  19. Vadgama JV, Wu Y, Shen D, Hsia S, Block J (2000) Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Anticancer Res 20:1391–1414

    CAS  PubMed  Google Scholar 

  20. Van Liew JR, Christensen AJ, de Moor JS (2014) Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research. J Cancer Surviv 8:521–531

    Article  PubMed  Google Scholar 

  21. Wang L, Gu Z, Zhai R, Zhao S, Luo L, Li D, Zhao X, Wei H, Pang Z, Wang L, Liu D, Wang Q, Gao C (2015) Efficacy of oral cryotherapy on oral mucositis prevention in patients with hematological malignancies undergoing hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials. PLOS ONE 10:e0128763

    Article  PubMed  PubMed Central  Google Scholar 

  22. Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ, Glück S, Silva O, Ahn ER (2014) Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin Breast Cancer 15:e1–e11

    Article  PubMed  Google Scholar 

  23. Zhong S, Jiang T, Ma T, Zhang X, Tang J, Chen W, Lv M, Zhao J (2014) Association between physical activity and mortality in breast cancer: a meta-analysis of cohort studies. Eur J Epidemiol 29:391–404

    Article  PubMed  Google Scholar 

  24. Zick SM, Sen A, Wyatt GK, Murphy SL, Arnedt JT, Harris RE (2016) Investigation of 2 types of self-administered acupressure for persistent cancer-related fatigue in breast cancer survivors: a randomized clinical trial. JAMA Oncol. doi:10.1001/jamaoncol.2016.1867

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Karsten Münstedt.

Ethics declarations

Interessenkonflikt

K. Münstedt, W. Gießler und T. Schopperth geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Münstedt, K., Gießler, W. & Schopperth, T. Komplementäre Onkologie und Prognose. Onkologe 23, 185–189 (2017). https://doi.org/10.1007/s00761-016-0155-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-016-0155-9

Schlüsselwörter

Keywords

Navigation